(MENAFN- Investors Ideas)
Veterinary artificial intelligence to make conference debut at Fetch!
SAN DIEGO, Calif. - December 13, 2018 (Investorideas.com Newswire) Vetology® Innovations, LLC , an advanced technology company serving the veterinary industry, is scheduled to attend the 2018 Fetch! DVM 360 Conference in San Diego, California from Dec. 13-16 and will debut the industry's first radiology-focused artificial intelligence (AI) solution.
Team members from Vetology® will be located at booth 1026 in Hall B2. Conference attendees stopping by the booth will be able get live demos of Vetology® AI, the company's AI radiology software, a first-of-its-kind tool that provides veterinary professionals with automated diagnostic analysis of patient radiographs.
The AI-powered cloud-based software was launched by Vetology® earlier this year and is a resource designed to help veterinarians evaluate radiographic studies.
Key features of Vetology® AI include automated heart evaluation tools, like heart size evaluation and Vertebral Heart Score calculation, comparative image matching across millions of unique X-Ray images and guided access to hundreds of thousands of clinical cases housed in Vetology's® database.
"With Vetology® AI, we are pioneering the next generation of tools for veterinary medicine. We've received an overwhelming amount of interest since launching this product and are excited to put it in the hands of veterinary professionals attending this year's Fetch conference," said Dr. Seth Wallack, DACVR, founder of Vetology® Innovations. "Terms like artificial intelligence can sound daunting, however, by having a hands-on experience, we know attendees will walk away with an understanding of how easy the technology is to implement in a hospital setting and the unique benefits for veterinarians and patients."
The AI software developed by Vetology® utilizes artificial neural networks, which are trained on known normal and abnormal x-ray images. Through this specialized machine learning process, the software is able to alert a veterinarian to potential medical abnormalities without human oversight.
With Vetology® AI heart evaluations, veterinarians are able to upload an image and receive a report in less than 90 seconds, allowing for more immediate feedback on heart cases.
Conference attendees visiting Vetology's® booth will be able to sign-up for a free 30-day trial of the AI software. Additionally, visitors can receive free swag like branded backpacks and mousepads.
Vetology® AI includes image storage, unlimited automated heart size evaluations and automated Vertebral Heart Score calculations. Additionally, sign up is simple and can be completed online at https://ai.vetology.net/ . This technology cost-effectively answers a rising unmet demand in the veterinary industry as more owner's request, and progressive veterinary hospitals deliver, a constantly advancing level of veterinary care.
About Vetology®
Founded in 2010 and headquartered in San Diego, California, Vetology® provides innovative and emerging technology solutions for the veterinary community. The company serves nearly 3,000 veterinary hospitals worldwide and offers SAAS products that facilitate the highest quality of patient care and services.
For more information about Vetology® AI and the company's products, visit https://ai.vetology.net or for other company products visit https://vetology.net
Vetology® is a registered trademark of the Veterinary Imaging Center of San Diego, Inc.
TechSectorStocks.com - investing ideas in tech stocks - mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)
Like Tech Stocks? View our Tech Stocks Directory Get News Alerts on Tech Stocks
More Info:
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
MENAFN1412201801420000ID1097829115
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.